111 – 120 of 381
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense.
(
- Contribution to journal › Article
-
Mark
Most 70- to 79-year-old patients with acute myeloid leukemia do benefit from intensive treatment.
(
- Contribution to journal › Letter
-
Mark
Combination of pegylated IFN-alpha 2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
(
- Contribution to journal › Article
-
Mark
beta(2)-Glycoprotein I: a novel component of innate immunity
(
- Contribution to journal › Article
-
Mark
Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials
(
- Contribution to journal › Article
-
Mark
CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization
(
- Contribution to journal › Article
-
Mark
Stress hematopoiesis requires Erg
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide
(
- Contribution to journal › Article
-
Mark
FLT3 expression initiates in fully multipotent mouse hematopoietic progenitor cells
(
- Contribution to journal › Article